Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus granulosus | beta-adrenergic receptor kinase | 0.0095 | 0.3667 | 0.9895 |
Echinococcus multilocularis | Carboxy terminal domain RNA polymerase II | 0.0013 | 0.0124 | 0.0335 |
Schistosoma mansoni | kinase | 0.0049 | 0.1681 | 0.4536 |
Leishmania major | protein kinase, putative,polo-like protein kinase, putative | 0.0096 | 0.3706 | 1 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0048 | 0.1627 | 0.1627 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0096 | 0.3706 | 0.3706 |
Echinococcus granulosus | 5'partial|histone lysine N methyltransferase SETDB2 | 0.003 | 0.0843 | 0.2276 |
Loa Loa (eye worm) | AGC/GRK/GRK protein kinase | 0.001 | 0.0024 | 0.0027 |
Plasmodium vivax | SET domain protein, putative | 0.0031 | 0.0892 | 1 |
Schistosoma mansoni | histone-lysine n-methyltransferase setb1 | 0.0031 | 0.0892 | 0.2406 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0096 | 0.3706 | 0.3706 |
Echinococcus granulosus | CTD small phosphatase protein like | 0.0013 | 0.0124 | 0.0335 |
Echinococcus granulosus | histone lysine methyltransferase setb | 0.0031 | 0.0892 | 0.2406 |
Trypanosoma cruzi | polo-like protein kinase, putative | 0.0096 | 0.3706 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0013 | 0.0124 | 0.0142 |
Loa Loa (eye worm) | hypothetical protein | 0.0013 | 0.0117 | 0.0135 |
Echinococcus multilocularis | serine:threonine protein kinase PLK1 | 0.0096 | 0.3706 | 1 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0095 | 0.3667 | 0.9895 |
Trypanosoma cruzi | polo-like protein kinase, putative | 0.0096 | 0.3706 | 1 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0095 | 0.3667 | 0.9895 |
Echinococcus granulosus | Carboxy terminal domain RNA polymerase II | 0.0013 | 0.0124 | 0.0335 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0096 | 0.3706 | 0.3706 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0048 | 0.1627 | 0.1627 |
Echinococcus multilocularis | histone lysine N methyltransferase SETMAR | 0.0031 | 0.0892 | 0.2406 |
Trichomonas vaginalis | nuclear lim interactor-interacting factor, putative | 0.0013 | 0.0124 | 0.0124 |
Loa Loa (eye worm) | PLK/PLK1 protein kinase | 0.0096 | 0.3706 | 0.4243 |
Echinococcus multilocularis | histone lysine methyltransferase setb histone lysine methyltransferase eggless | 0.0031 | 0.0892 | 0.2406 |
Schistosoma mansoni | histone-lysine n-methyltransferase setb1 | 0.0031 | 0.0892 | 0.2406 |
Brugia malayi | Probable G protein-coupled receptor kinase F19C6.1, putative | 0.001 | 0.0024 | 0.0027 |
Brugia malayi | Carboxy-terminal domain RNA polymerase II polypeptide A smallphosphatase 1 | 0.0013 | 0.0124 | 0.0142 |
Schistosoma mansoni | histone-lysine n-methyltransferase suv9 | 0.0031 | 0.0892 | 0.2406 |
Trichomonas vaginalis | nuclear lim interactor-interacting factor, putative | 0.0013 | 0.0124 | 0.0124 |
Schistosoma mansoni | hypothetical protein | 0.0013 | 0.0117 | 0.0317 |
Echinococcus multilocularis | 0.0013 | 0.0124 | 0.0335 | |
Brugia malayi | Pre-SET motif family protein | 0.0031 | 0.0892 | 0.1021 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0096 | 0.3706 | 0.3706 |
Onchocerca volvulus | Serine\/threonine kinase homolog | 0.0096 | 0.3706 | 0.309 |
Giardia lamblia | Kinase, PLK | 0.0096 | 0.3706 | 1 |
Loa Loa (eye worm) | AGC/GRK/BARK protein kinase | 0.0095 | 0.3667 | 0.4198 |
Brugia malayi | Pre-SET motif family protein | 0.0214 | 0.8735 | 1 |
Trichomonas vaginalis | nuclear lim interactor-interacting factor, putative | 0.0013 | 0.0124 | 0.0124 |
Trichomonas vaginalis | set domain proteins, putative | 0.0243 | 1 | 1 |
Echinococcus granulosus | serine:threonine protein kinase PLK1 | 0.0096 | 0.3706 | 1 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0096 | 0.3706 | 0.3706 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0096 | 0.3706 | 0.3706 |
Loa Loa (eye worm) | pre-SET domain-containing protein family protein | 0.0214 | 0.8735 | 1 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0096 | 0.3706 | 0.3706 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0096 | 0.3706 | 1 |
Toxoplasma gondii | histone lysine methyltransferase SET/SUV39 | 0.0031 | 0.0892 | 1 |
Echinococcus multilocularis | beta adrenergic receptor kinase | 0.0095 | 0.3667 | 0.9895 |
Trichomonas vaginalis | dullard protein, putative | 0.0013 | 0.0124 | 0.0124 |
Entamoeba histolytica | NLI interacting factor-like phosphatase domain-containing protein | 0.0013 | 0.0124 | 0.0335 |
Brugia malayi | serine/threonine-protein kinase plk-2 | 0.0096 | 0.3706 | 0.4243 |
Trichomonas vaginalis | dullard protein, putative | 0.0013 | 0.0124 | 0.0124 |
Schistosoma mansoni | histone-lysine n-methyltransferase setb1 | 0.0031 | 0.0892 | 0.2406 |
Schistosoma mansoni | serine/threonine protein kinase | 0.001 | 0.0024 | 0.0064 |
Schistosoma mansoni | nuclear lim interactor-interacting factor (nli-interacting factor) (nli-if) | 0.0013 | 0.0124 | 0.0335 |
Trypanosoma brucei | polo-like protein kinase | 0.0096 | 0.3706 | 1 |
Schistosoma mansoni | nuclear lim interactor-interacting factor (nli-interacting factor) (nli-if) | 0.0013 | 0.0124 | 0.0335 |
Plasmodium falciparum | NLI interacting factor-like phosphatase, putative | 0.0013 | 0.0124 | 0.5 |
Echinococcus multilocularis | G protein coupled receptor kinase 1 | 0.0086 | 0.3245 | 0.8757 |
Trichomonas vaginalis | dullard protein, putative | 0.0013 | 0.0124 | 0.0124 |
Entamoeba histolytica | serine/threonine protein kinase, putative | 0.0096 | 0.3706 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0031 | 0.0892 | 0.1021 |
Echinococcus granulosus | G protein coupled receptor kinase 1 | 0.0086 | 0.3245 | 0.8757 |
Trichomonas vaginalis | nuclear lim interactor-interacting factor, putative | 0.0013 | 0.0124 | 0.0124 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.